Cannovex

Agoralaan Building Abis /
3590 Diepenbeek
BE
Cannovex
Foundation date
06/08/2016
Sector
#Biotechnology - otherSubsector
Therapeutic areas
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the eye
- #Diseases of the nervous system
- #Endocrine - nutritional and metabolic diseases
- #Mental and behavioural disorders
- #Musculoskeletal system and connective tissue
- #Neoplasms / cancer / oncology
- #Respiratory system
- #Skin and subcutaneous tissue
Cannovex is a Benelux-origin biotech company which develops cannabinoid-based medicines to improve the lives of patients worldwide. Over a two year period, Cannovex has conducted an in-depth and exhaustive study of medical literature on this subject, and continues to monitor all scientific publications. These efforts establish Cannovex as the designated conversation partner, sounding board and source of information on cannabinoid medicines for all stakeholders.
Based on the insights resulting from the above-mentioned research, Cannovex is now planning the development of cannabinoid-based medicines in specific therapeutic areas and for well-defined indications. Cannovex aims to set up clinical studies, in collaboration with EU university hospitals, to provide proofs of concept (PoC). Based on these PoCs, Cannovex will explore partnerships with pharmaceutical companies to conduct end-stage clinical trials, to apply for market authorisation with European Medicines Agency (EMA) and similar authorities, and to bring our cannabinoid medicinal products to the markets worldwide.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Celyad Oncology appoints Georges Rawadi as its new CEO
Tuesday March 28th 2023
Read more
-
BioLizard appoints Paul Vauterin as Chief Technology Officer
Monday March 27th 2023
Read more
-
ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI
Monday March 27th 2023
Read more
Jobs
More jobs-
-
28/03/23
East Flanders
Postdoc researcher: Unravelling proteostasis machineries in jasmonate signalling in tomato
Permanent
VIB -
28/03/23
East Flanders
PhD student: Phosphoregulation in jasmonate-mediated plant stress responses
Permanent
VIB